Switching on brain cells: The Nobel-winning science of optogenetics
In optogenetics, scientists control neurons by stimulating them with light—potentially unlocking breakthroughs for conditions such as dementia, depression and blindness.
In 2014, three scientists - U.S. neurologist Karl Deisseroth, German Peter Hegemann, and German Georg Nagel - were awarded the Nobel Prize in Medicine for their groundbreaking work in optogenetics. This revolutionary technique allows researchers to control neurons by stimulating them with light. The concept began with the discovery of channelrhodopsin, a light-sensitive protein found in green algae, by Hegemann and Nagel.
Deisseroth then introduced this protein into cells and controlled its activity with light, effectively switching a neuron's signal on or off with precision. By manipulating specific neurons, scientists can observe which areas influence various functions. Nobel committee member Abdel El Manira highlighted the potential of optogenetics to shed light on functions ranging from parental behavior to fundamental physiological drives like thirst and water intake.
The technology has already been applied in treating degenerative blindness and modulating memory-related activity. Researchers are currently exploring its potential to treat conditions such as depression, PTSD, and addiction. While optogenetics has already shown promising results in vision restoration, the true impact of this Nobel-winning science may take years to fully realize, as its application in understanding and treating neurological and psychiatric diseases continues to be researched.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.